OCSNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as OCSAW
Oculis Holding AG
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 4, 2026
$7.32+0.03 (+0.41%)
Close on Oct 19, 2026
Dividends
Oculis has not reported a dividend
No dividend per share appears in Oculis's annual filings since fiscal 2019.